A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs ...Middle East

Time - News
A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs
As popular as the new group of weight-loss drugs like Wegovy and Zepbound are, not everyone responds to them in the same way. In a new presentation at the Digestive Disease Week conference in Washington, Mayo Clinic associate professor of medicine Dr. Andres Acosta reported that a genetic test he developed can identify which people are most likely to respond to semaglutide (Wegovy) and which are not. The test, called MyPhenome, from a company Acosta co-founded called Phenomix, relies on a combination of genetic and other factors to categorize people into different types of weight gain. Acosta identified about two dozen genes linked to obesity, and more than 6,000 variants of th

Hence then, the article about a new test predicts who will benefit most from weight loss drugs was published today ( ) and is available on Time ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs )

Apple Storegoogle play

Last updated :

Also on site :